Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials

被引:7
作者
Pavasini, Rita [1 ]
Serenelli, Matteo [1 ]
Gallo, Francesco [1 ]
Bugani, Giulia [1 ]
Geraci, Salvatore [2 ]
Vicinelli, Paolo [3 ]
Campo, Gianluca [1 ,4 ]
机构
[1] Azienda Osped Univ Ferrara, Cardiol Unit, Ferrara, Italy
[2] Osped S Giovanni di Dio, Cardiol Unit, Agrigento, Italy
[3] Osped Fornaroli, Cardiol Unit, ASST Milanese Ovest, Magenta, Italy
[4] Maria Cecilia Hosp, ES Hlth Sci Fdn, GVM Care & Res, Cotignola, Italy
关键词
Bioresorbable vascular scaffold (BVS); absorb; meta-analysis; DRUG-ELUTING STENT; OPTICAL COHERENCE TOMOGRAPHY; METALLIC STENTS; IMPLANTATION; OVERLAP;
D O I
10.21037/jtd.2017.06.59
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: In the last years bioresorbable vascular scaffold (BVS) become a new therapeutic option for interventional cardiologists, with the advantage of a scaffold inducing a possible vessel wall restoration. Nevertheless, several trials tried to prove the safety and efficacy profile of scaffolds, but with conflicting results. Methods: A systematic review and meta-analysis was performed. The search was carried out in PubMed, Google Scholar, Biomed Central and Cochrane Library between January and March 2017. Inclusion criteria: randomized clinical trials (RCT) comparing the Absorb BVS versus durable polymer cobalt-chromium Everolimus Eluting Stent. The outcomes analysed were all-cause mortality, cardiac death, ischemia-driven target lesion revascularization, target vessel myocardial infarction (MI), target lesion failure (TLF)/device oriented composite endpoints (DOCE), and device thrombosis. Fixed-effect meta-analysis was performed. Data were expressed as odds ratio (OR). Results: Overall 5,674 patients were included (mean age 62.2 +/- 1.31 in drug eluting stents (DES) group vs. 62 +/- 1,47 in BVS group; P=0.942). DOCE (OR 1.16, 95% CI: 0.90-1.48; P=0.259, I-2=0%), cardiac death (OR 0.86, 95% CI: 0.52-1.40; P=0.537, I-2=0%) and all-cause death (OR 0.78, 95% CI: 0.53-1.15; P=0.205, I-2=15%) did not differ between BVS and DES. Conversely, ischemia-driven target lesion revascularization was more frequent in the BVS group (OR 1.32, 95% CI: 1.01-1.73; P=0.039, I-2=0%), as well as device thrombosis (2.2% vs. 0.6%, OR 2.94, 95% CI: 1.71-5.05, P=0.0001, I-2=0%) and target-vessel MI (5.4% vs. 3%, OR 1.66, 95% CI: 1.25-2.21, P=0.001, I-2=0%). Conclusions: The implantation of BVS is associated with an increased risk of device thrombosis, ischemiadriven target lesion revascularization and target vessel MI. If longer follow-up or different implantation technique may change these findings should be addressed in future trials.
引用
收藏
页码:S887 / S897
页数:11
相关论文
共 34 条
[1]   Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) [J].
Biscaglia, Simone ;
Ugo, Fabrizio ;
Ielasi, Alfonso ;
Secco, Gioel Gabrio ;
Durante, Alessandro ;
D'Ascenzo, Fabrizio ;
Cerrato, Enrico ;
Balghith, Mohammed ;
Pasquetto, Giampaolo ;
Penzo, Carlo ;
Fineschi, Massimo ;
Bonechi, Francesco ;
Templin, Christian ;
Menozzi, Mila ;
Aquilina, Matteo ;
Rognoni, Andrea ;
Capasso, Piera ;
Di Mario, Carlo ;
Brugaletta, Salvatore ;
Campo, Gianluca .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 208 :40-45
[2]   Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison [J].
Biscaglia, Simone ;
Campo, Gianluca ;
Tebaldi, Matteo ;
Tumscitz, Carlo ;
Pavasini, Rita ;
Fileti, Luca ;
Secco, Gioel G. ;
Di Mario, Carlo ;
Ferrari, Roberto .
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2016, 32 (02) :211-223
[3]   Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system [J].
Biscaglia, Simone ;
Secco, Gioel G. ;
Tumscitz, Carlo ;
Di Mario, Carlo ;
Campo, Gianluca .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 182 :1-3
[4]   Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials [J].
Bourantas, Christos V. ;
Zhang, Yaojun ;
Farooq, Vasim ;
Garcia-Garcia, Hector M. ;
Onuma, Yoshinobu ;
Serruys, Patrick W. .
CURRENT CARDIOLOGY REPORTS, 2012, 14 (05) :626-634
[5]   Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds A Review of the Published Data, Practical Recommendations, and Future Directions [J].
Capodanno, Davide ;
Angiolillo, Dominick J. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (05) :425-437
[6]  
Cooper H., 2009, The handbook of research synthesis and Metaanalysis, V2nd, DOI DOI 10.7758/9781610448864
[7]   Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold [J].
Costa, Jose De Ribamar, Jr. ;
Abizaid, Alexandre ;
Bartorelli, Antonio L. ;
Whitbourn, Robert ;
van Geuns, Robert Jan ;
Chevalier, Bernard ;
Perin, Marcos ;
Seth, Ashok ;
Botelho, Roberto ;
Serruys, Patrick W. .
EUROINTERVENTION, 2015, 11 (02) :141-148
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Vascular responses to drug eluting stents - Importance of delayed healing [J].
Finn, Aloke V. ;
Nakazawa, Gaku ;
Joner, Michael ;
Kolodgie, Frank D. ;
Mont, Erik K. ;
Gold, Herman K. ;
Virmani, Renu .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) :1500-1510
[10]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441